BB's Stock Haven

[Martin Murray]

CHHH News:

China Health Holding Announces Additional US$300,000 Investment by Chief Executive Officer Julianna Lu

Tuesday , March 13, 2007 11:33 ET

LAS VEGAS, March 13 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide, announced today the Company's board of directors on March 12th, 2006, approved the issuance of 5,000,000 shares of the Company's common stock to Ms. Julianna Lu, China Health Holding's Founder and Chief Executive Officer.

The stocks were issued as consideration for the forgiveness of loans in the aggregate amount of US$300,000 previously advanced to the Company by Ms. Lu. As part of the transaction, the Company will issue Ms. Lu five-year warrants to purchase 10,000,000 shares of the Company's common stock with an exercise price of US$0.10 per share. The Company will also issue ten-year warrants to purchase 10,000,000 shares of the Company's common stock with an exercise price of US$0.20 per share. The warrants have piggy back registration rights and voting rights with respect to the shares of common stock issuable upon exercise of the warrants. The Company claims an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") with respect to the foregoing, pursuant to Section 4(2) of the Act and/or Regulation D promulgated thereunder.

With the latest loan forgiveness, Ms. Julianna Lu now has invested a total of $750,000 in cash in China Health Holdings since the beginning of 2006 in exchange for stocks and warrants. This amount includes US$150,000.00 for the purchase of 1,000,000 Series A Preferred Stocks in early 2006; and A total of US$300,000.00 for the purchase of 10,000,000 common stocks, in October, 2006, as part of the transaction, the Company has issued Ms. Lu five-year warrants to purchase 10,000,000 shares of the Company's common stock with an exercise price of US$0.10 per share and issued additional ten-year warrants to purchase 10,000,000 shares of the Company's common stock with an exercise price of US$0.20 per share. All the warrants have piggy back registration rights and voting rights with respect to the shares of common stock issuable upon exercise of the warrants, as announced in October, 2006. As of December 12 2006, Ms. Lu held more than 63.75% of the Company's total issued and outstanding stock, including 1,250,000 shares of Series A Preferred Stock. In next 10 years, Ms. Julianna Lu's warrants exercise will bring the Company for a total US$6,000,000.00 cash investment.

As the Company's Founder and CEO, Ms. Julianna Lu, has substantially contributed to China Health Holding financially and creatively and is committed to developing it into a successful global pharmaceutical corporation with the vision of improving the world pharmaceutical industry.

"As a fast growing, highly fragmented pharmaceutical industry, we believe that China's pharmaceutical industry presents strong investment opportunities," said Ms. Julianna Lu. "In fact, last year China exported traditional Chinese medicine, or TCM, to 164 countries and regions around the world with export earnings reaching an all-time high of US$830 million, according to the China Association of Traditional Chinese Medicine."

"With a pipeline of signed acquisitions deals with China Major Pharmaceutical Companies and an experienced management team that truly understands the Pharmaceutical Industry, We are confident that China Health Holding will reach our development goals and deliver strong value to our shareholders," added Ms. Julianna Lu, the Company's Founder and CEO.

The Company is continuing to prepare for a listing on a larger exchange such as NASDAQ or American Stock Exchange in the next 12 to 18 months. In the next 12 to 48 months approximately, the Company plans to continue partnering with China SFDA certified drug producers, China GMP accredited manufacturing facilities, research and development centers and Universities. Further pending acquisitions are expected to bring total assets to US$100 million, gross revenue of approximately US$100 million and an annual net income of US$10 to 15 million in next 12 to 48 months approximately.

About China Health Holding

China Health Holding, Inc. is a development stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide. It has extensive expertise in the field of traditional Chinese medicine and the Chinese pharmaceutical industry. Its immediate goal is the profitable penetration of the growing global and China pharmaceutical industry and market through acquisitions of major pharmaceutical companies in the People's Republic of China and worldwide. Its long-term plans include the development of a pharmaceutical drug pipeline and technology based on its knowledge of traditional Chinese medicine and the pharmaceutical industry in the People's Republic of China.

The company has two wholly-owned subsidiaries: (i) China Health World Pharmaceutical Corporation, which will develop, manufacture and commercialize natural medications for diseases and conditions related to diabetes, cardiovascular disease and neurological disorders; and (ii) China Health World Trade Corporation, which will develop China Health's retail/franchise infrastructure along with worldwide branding, multimedia marketing and multi- channel distribution to global customers and markets.

China Health owns the exclusive worldwide rights to a total of 134 proprietary natural herbal medicinal products/formulas in two natural herbal medicinal product lines: King of Herbs and Taoist Medicinal. Please visit http://www.chinahealthholding.com for the Company's profile.

For worldwide investor and media inquiries, please contact:

China Health Holding, Inc. (Las Vegas)
Mr. Xiaofei Yu
The President/Executive Director
Corporate Development
Tel: [phone] and [phone]
Tel: [phone] (Beijing, China) (Text Message)
Email: [e-mail]
http://www.chinahealthholding.com

Mr. Rory Macpherson
Senior Associate
Ogilvy Public Relations Worldwide
[phone]
Email: [e-mail]

Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.

SOURCE China Health Holding, Inc.


--------------------------------------------------------------------------------

Contacts:

Mr. Xiaofei Yu
President-Executive Director of Corporate Development of China Health Holding, Inc.
Las Vegas
Tel: [phone]
877-883-0979
Tel: [phone]
Beijing
China
Text Message
[e-mail]

Mr. Rory Macpherson
Senior Associate of Ogilvy Public Relations Worldwide
for China Health Holding, Inc.
[phone]
[e-mail]